Spatiotemporal dynamics of the host-tumor metabolic interface: Implications for precision nutritional oncology.
Precision nutritional oncology could potentially enhance cancer treatment by targeting metabolic interactions, but further research is needed to validate these concepts in clinical settings.
Where it sits
this study against the rest of the bofanglutide corpusSummary and findings
This review explores the metabolic interactions between host and tumor environments, emphasizing the role of diet-induced metabolic shifts in cancer progression. It proposes a precision nutritional oncology paradigm using multi-omic biomarkers to track metabolic changes. The review highlights the potential of integrating precision nutrition into oncologic care to exploit tumor vulnerabilities.
Abstract
Beyond somatic initiation, cancer progression is governed by a multidimensional systemic metabolic architecture. This permissive macroenvironment, shaped by systemic nutrient fluxes, endocrine networks, and microbial co-metabolites, sustains tumor bioenergetics and immune evasion. Bridging the current translational gap requires decoding the spatiotemporal reciprocity between diet-induced metabolic shifts, tumor microenvironment plasticity, and genotoxic therapy responses. In this review, we deconstruct the host-tumor metabolic interface through a systems biology framework, tracing the biotransformation of macro-dietary inputs into subcellular oncogenic and immunological signals. We move beyond traditional nutritional epidemiology to define a precision nutritional oncology paradigm that leverages high-resolution multi-omic biomarkers to track real-time systemic flux, the spatial ecosystem of the microbiome as a localized metabolic bioreactor, and context-dependent metabolic regulation to exploit transient tumor vulnerabilities. We emphasize the need for precise spatiotemporal calibration, particularly during acute refeeding windows, to prevent paradoxical therapy resistance or accelerated cachexia. Finally, we envision a future in which precision nutrition is seamlessly integrated into oncologic care, powered by artificial intelligence and digital gut twins for <i>in silico</i> modeling. By incorporating the broader chemical exposome and addressing structural socioeconomic determinants through frameworks such as the Planetary Health Diet, we outline a roadmap toward global health equity and enhanced metabolic resilience in cancer survivorship.
Background
Cancer progression is not solely driven by genetic mutations but also by complex systemic metabolic interactions. Understanding these interactions is crucial for developing precision nutritional strategies in oncology. This study addresses the need to decode the metabolic interface between host and tumor to improve cancer treatment outcomes.
Methods
This is a review article that utilizes a systems biology framework to analyze existing literature on the metabolic interactions between diet, tumor microenvironment, and cancer therapy responses. It does not involve new experimental data or specific study populations.
Results
The review identifies the role of systemic nutrient fluxes and endocrine networks in sustaining tumor bioenergetics and immune evasion. It suggests that precision nutrition, guided by multi-omic biomarkers, could exploit transient tumor vulnerabilities and improve cancer care.
Interpretation
The review builds on existing knowledge by proposing a novel framework for precision nutritional oncology. However, the lack of new experimental data limits the ability to assess the clinical significance of the proposed strategies. The integration of precision nutrition into cancer care remains theoretical at this stage.
Key findings
- Cancer progression is influenced by systemic nutrient fluxes and endocrine networks.
- The tumor microenvironment is shaped by diet-induced metabolic shifts.
- Multi-omic biomarkers can track real-time systemic metabolic flux.
- Precision nutrition could prevent therapy resistance or cachexia.
- Artificial intelligence and digital gut twins may aid in modeling metabolic interactions.
Limitations
- No new experimental data provided
- Relies on existing literature and theoretical models
- Lacks quantitative findings
- Proposals remain theoretical